Table 2.
Changes in proteinuria | P trend | Per degree decrease | |||
---|---|---|---|---|---|
Elevated proteinuria | Stable proteinuria | Reduced proteinuria | |||
All participants | |||||
Model 1 | 1.92 (1.66–2.23) | 1 | 0.75 (0.60–0.95) | <0.0001 | 0.71 (0.67–0.75) |
Model 2 | 1.67 (1.44–1.94) | 1 | 0.71 (0.56–0.90) | <0.0001 | 0.75 (0.71–0.79) |
Model 3 | 1.66 (1.43–1.92) | 1 | 0.71 (0.56–0.90) | <0.0001 | 0.75 (0.71–0.80) |
Model 4 | 1.54 (1.33–1.79) | 1 | 0.70 (0.55–0.89) | <0.0001 | 0.78 (0.73–0.82) |
Diabetes∗ | |||||
Model 4 | 1.75 (1.43–2.15) | 1 | 0.73 (0.53–0.99) | <0.0001 | 0.74 (0.69–0.80) |
Prediabetes | |||||
Model 4 | 1.34 (1.07–1.68) | 1 | 0.68 (0.47–0.98) | 0.0002 | 0.82 (0.75–0.90) |
Model 1: adjusted for the levels of baseline proteinuria; model 2: adjusted for age, gender, and baseline proteinuria; model 3: adjusted for age, gender, level of education, income, smoking, alcohol abuse, amount of physical activity, body mass index, and baseline proteinuria; model 4: adjusted for variables in model 3 plus history of hypertension, diabetes, dyslipidemia, total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, fasting plasma glucose, and creatinine. ∗The P value of interaction between proteinuria changes and diabetes status for all-cause mortality is 0.4274.